Neuromodulation + Cognitive Training for Post-Concussion Depression
Trial Summary
What is the purpose of this trial?
The primary goal of this clinical trial is to evaluate whether Personalized Augmented Cognitive Training (PACT) plus intermittent theta burst stimulation (iTBS) is effective for treating depression in Service Members, Veterans, and civilians who have sustained a mild TBI. Participants will receive PACT plus 20 sessions of iTBS or sham iTBS over 4 weeks. Assessments will occur at baseline, 2 weeks, 4 weeks, and 8 weeks. Researchers will compare the PACT+iTBS group to the PACT+sham iTBS group to see if PACT+iTBS is associated with more depression improvement.
Will I have to stop taking my current medications?
The trial requires that participants have been stable on their psychiatric medications for at least 6 weeks and do not change these medications during the study. However, if you are taking lorazepam 2 mg or greater daily, any anticonvulsant, or medication that lowers the seizure threshold, you may not be eligible to participate.
What data supports the effectiveness of this treatment for post-concussion depression?
Intermittent theta burst stimulation (iTBS) has shown promise in treating depression and improving cognitive function in conditions like traumatic brain injury and major depressive disorder. Studies suggest that iTBS, especially when combined with cognitive training, may enhance recovery and support functional gains in complex neuropsychiatric conditions.12345
Is the treatment of iTBS and cognitive training safe for humans?
How is the treatment for post-concussion depression using iTBS and PACT different from other treatments?
This treatment combines intermittent theta burst stimulation (iTBS), a non-invasive brain stimulation technique, with personalized augmented cognitive training (PACT) to target both brain function and cognitive skills, making it unique compared to standard treatments that typically focus on either medication or therapy alone.3891011
Research Team
Elizabeth Twamley, PhD
Principal Investigator
UC San Diego
Eligibility Criteria
This trial is for Service Members, Veterans, and civilians aged 18-65 with post-mTBI depression who can commit to the treatment schedule. They must have moderate to severe depressive symptoms, no MRI or TMS contraindications, stable psychiatric medications for 6 weeks, and meet criteria for a current Major Depressive Episode.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Personalized Augmented Cognitive Training (PACT) plus 20 sessions of intermittent theta burst stimulation (iTBS) or sham iTBS over 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- iTBS
- Personalized Augmented Cognitive Training (PACT)
- sham iTBS
iTBS is already approved in United States for the following indications:
- Treatment-resistant depression
- Major depressive disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
San Diego Veterans Healthcare System
Collaborator